Chloe Thio is an Infectious Disease physician affiliated with Johns Hopkins University. OpenAlex indexes 233 publications with 13,494 citations (h-index 61). By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
52.9%Calcium channel blocker36.5%Amlodipine Besylate100%Part D<11 patientsStatin16.5%Atorvastatin Calcium100%Part D<11 patientsNervous system
18.8%Gabapentinoids18.8%Gabapentin100%Part D<11 patientsRespiratory
15.3%Leukotriene Receptor Antagonist15.3%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
16 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- HBV cccDNA transcriptional silencing with and without HIV
Johns Hopkins University
FY2026$818,465R01AI181659
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment
Journal of Clinical Investigation
2022 - Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016
Clinical Infectious Diseases
2019 - Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy
The Lancet Infectious Diseases
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Pradeep Ramulu, MD
Johns Hopkins University
Nicholas Maragakis, MD
Johns Hopkins University
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”